Clinical trials

Home
Clinical trials

Exploring new ways to improve and extend peoples' lives

Our clinical trials aim to assess the potential of our investigational treatments in a clearly defined group of patients who meet specific eligibility criteria, enabling us to evaluate safety and clinical effectiveness.

A full list of clinical trials supported by Autolus, and our collaborators is below and all further information can be found by following the links below.

Program	Phase	Indication	Study Name	Further Information
obe-cel	2	Pediatric B-ALL	CATULUS	NCT06173518
obe-cel	1	Systemic Lupus Erythematosus	CARLYSLE	NCT06333483
obe-cel	2	Lupus Nephritis	LUMINA	NCT07053800
obe-cel	1	Progressive Multiple Sclerosis	BOBCAT	NCT07139743
obe-cel*	1	B-NHL & CLL	ALLCAR	NCT06173518
obe-cel*	1	Primary CNS Lymphoma	CAROUSEL	NCT04443829
AUTO1/22*	1	Pediatric B-ALL	CARPALL	NCT02443831
AUTO8	1	Multiple Myeloma	MCARTY	NCT04795882
AUTO8*	1	Light Chain Amyloidosis	ALARIC	ISRCTN49320109
AUTO4/5	Preclinical	TRBC1/2+ Peripheral TCL	LibrA T1	NCT03590574
AUTO6NG*§	1	Neuroblastoma	MAGNETO	NCT05990751
AUTO9*	Preclinical	Acute Myeloid Leukemia	TBD

* Collaboration with UCL
§ BioNTech holds option to co-fund and co-commercialise

If you would like to obtain further information about our ongoing clinical studies, please reach out to us at [email protected].